HLA B*15:02, Carbamazepine Sensitivity
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms | HLAB15 |
| Cerner Primary Mnemonic | HLA B*15:02, Carbamazepine Sensitivity |
| EPIC Display Name | HLA B*15:02, Carbamazepine Sensitivity |
| Allscripts (AEHR) Order Name | HLA B*15:02, Carbamazepine Sensitivity |
| Sunrise Clinical Manager (SCM) Order Name | HLA B*15:02, Carbamazepine Sensitivity |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
HLAMETHOD HLA-BCARBSENSA1 HLA-BCARBSENSA2 |
| Clinical Info |
Use to identify patients who may be at risk for developing Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) prior to treatment with carbamazepine (CBZ). This test has been recommended for patients of Asian descent who are being considered for carbamazepine therapy. The utility of this test for patients of other ethnic backgrounds has not been established. |
| Specimen Type |
Blood, Swab |
| Container |
Whole blood or buccal swabs |
| Collection Instructions |
Container/Tube: Collect 7 mL whole blood (2 Lavender Top Tubes) or 4 buccal swabs Transport Temperature: Maintain whole blood at room temperature or refrigerate. Keep buccal swabs dry and at room temperature |
| Transport Instructions |
Maintain whole blood at room temperature or refrigerate. Keep buccal swabs dry and at room temperature |
| Specimen Stability |
Room Temperature or Refrigerated |
| Methodology |
Sequence-based typing (SBT), sequence-specific oligonucleotide probes (SSOP), and/or sequence-specific primers (SSP) as needed to obtain the required resolution. |
| Days Performed |
TAT: 4-8 Days |
| Performing Laboratory |
LabCorp |
| CPT |
81381 |
| PDM |
225706 |
Desired Epic Build HLA B*15:02, Carbamazepine Sensitivity
| Cerner Primary Mnemonic: | HLA B*15:02, Carbamazepine Sensitivity | ||||||||||||
| PDM | 225706 | ||||||||||||
| Informatics - Workgroup | Molecular-send outs | ||||||||||||
| Synonyms * | HLAB15 | ||||||||||||
| Display Name * | HLA B*15:02, Carbamazepine Sensitivity | ||||||||||||
| Order Entry Specimen Sources * | |||||||||||||
| Order Entry Specimen Types |
Blood
Buccal Swab
| ||||||||||||
| Specimen Navigator Specimen Types | |||||||||||||
| Specimen Navigator Specimen Sources | |||||||||||||
| Specimen Navigator Short Name | |||||||||||||
| Ordering info (EPIC SmartText) | Use to identify patients who may be at risk for developing Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) prior to treatment with carbamazepine (CBZ). This test has been recommended for patients of Asian descent who are being considered for carbamazepine therapy. The utility of this test for patients of other ethnic backgrounds has not been established. | ||||||||||||
| IP Orderable | Yes | ||||||||||||
| OP Orderable | Yes | ||||||||||||
|
AOEs * | |||||||||||||
| AP AOEs | |||||||||||||
| Special History | No | ||||||||||||
| Build Comments | |||||||||||||
| Filter * | genetics | ||||||||||||
| Procedure Category Change | |||||||||||||
Cerner Results
| |||||||||||||
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 114680 | ||||||||||||||||||||||||
| Pdm | 225706 | ||||||||||||||||||||||||
| Order Display Name | HLA B*15:02, Carbamazepine Sensitivity | ||||||||||||||||||||||||
| Procedure Name | HLA B*15:2, CARBAMAZEPINE SENSITIVITY | ||||||||||||||||||||||||
| Procedure Master Number | LAB11148 | ||||||||||||||||||||||||
| Short Procedure Name | HLA B*15:2, CARBAMAZEPINE SENSITIVITY | ||||||||||||||||||||||||
| Category Code | 1.0 | ||||||||||||||||||||||||
| Category Code Record Name | LAB BLOOD ORDERABLES | ||||||||||||||||||||||||
| Synonyms | HLAB15 | ||||||||||||||||||||||||
| Clinically Active | |||||||||||||||||||||||||
| Orderable | |||||||||||||||||||||||||
| Performable | |||||||||||||||||||||||||
| Filter Genomics | Generic Genomics Procedure | ||||||||||||||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/114680 | ||||||||||||||||||||||||
| Ordering Instructions | |||||||||||||||||||||||||
| Default Specimen Type | Blood | ||||||||||||||||||||||||
| Specimen Type Pick List | |||||||||||||||||||||||||
| Specimen Type List | |||||||||||||||||||||||||
| Op Specimen Type List | |||||||||||||||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||||||||
| Specimen Source List | |||||||||||||||||||||||||
| Op Specimen Source List | |||||||||||||||||||||||||
| Ip Lab Test Components For Report | |||||||||||||||||||||||||
| Op Lab Test Components For Report | |||||||||||||||||||||||||
| Order Questions | [] | ||||||||||||||||||||||||
| Order Questions Record Name | |||||||||||||||||||||||||
| Inpatient Order Questions | [] | ||||||||||||||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||||||||||||||
| Order Specific Question Override | |||||||||||||||||||||||||
| Inpatient Question Override | |||||||||||||||||||||||||
| Location Restrict List Ip | |||||||||||||||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||||||||||||||
| Location Restrict List Include Ip | |||||||||||||||||||||||||
| Location Restrict List Op | |||||||||||||||||||||||||
| Location Restrict List Op Record Name | |||||||||||||||||||||||||
| Location Restrict List Includes Op | |||||||||||||||||||||||||
| Edp Amb Order Specific Questions Record Name | |||||||||||||||||||||||||
| Edp Ip Order Specific Questions Record Name | |||||||||||||||||||||||||
| Edp Ip Specimen Source | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||||||||||||||
| Edp Op Specimen Source | |||||||||||||||||||||||||
| Edp Ip Specimen Type | Blood | ||||||||||||||||||||||||
| Edp Op Specimen Type | |||||||||||||||||||||||||
| Derived Edp Ip Buttons S | Blood, Central Line Blood, Venous Blood, Capillary Blood, Arterial | ||||||||||||||||||||||||
| Derived Edp Ip Buttons T | |||||||||||||||||||||||||
| Derived Edp Op Buttons S | |||||||||||||||||||||||||
| Derived Edp Op Buttons T | |||||||||||||||||||||||||
| Ip Orderable | 1 | ||||||||||||||||||||||||
| Op Orderable | 1 | ||||||||||||||||||||||||
| EPIC OP AOEs | |||||||||||||||||||||||||
| EPIC IP AOEs | |||||||||||||||||||||||||
EPIC Components (results)
| |||||||||||||||||||||||||